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Hypoxic Induction of the Regulator of G-Protein
Signalling 4 Gene Is Mediated by the Hypoxia-Inducible
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Abstract
The transcriptional response to hypoxia is largely dependent on the Hypoxia Inducible Factors (HIF-1 and HIF-2) in
mammalian cells. Many target genes have been characterised for these heterodimeric transcription factors, yet there is
evidence that the full range of HIF-regulated genes has not yet been described. We constructed a TetON overexpression
system in the rat pheochromocytoma PC-12 cell line to search for novel HIF and hypoxia responsive genes. The Rgs4 gene
encodes the Regulator of G-Protein Signalling 4 (RGS4) protein, an inhibitor of signalling from G-protein coupled receptors,
and dysregulation of Rgs4 is linked to disease states such as schizophrenia and cardiomyopathy. Rgs4 was found to be
responsive to HIF-2a overexpression, hypoxic treatment, and hypoxia mimetic drugs in PC-12 cells. Similar responses were
observed in human neuroblastoma cell lines SK-N-SH and SK-N-BE(2)C, but not in endothelial cells, where Rgs4 transcript is
readily detected but does not respond to hypoxia. Furthermore, this regulation was found to be dependent on
transcription, and occurs in a manner consistent with direct HIF transactivation of Rgs4 transcription. However, no HIF
binding site was detectable within 32 kb of the human Rgs4 gene locus, leading to the possibility of regulation by long-
distance genomic interactions. Further research into Rgs4 regulation by hypoxia and HIF may result in better understanding
of disease states such as schizophrenia, and also shed light on the other roles of HIF yet to be discovered.
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Introduction
Oxygen is critical for the survival of metazoan cells, and as such
there is an adaptive response to chronic cellular hypoxia, involving
activation of the Hypoxia Inducible Factor (HIF) pathway. HIF is
a heterodimeric transcription factor which binds at over 100
genomic sites to activate transcription of hypoxia-adaptive genes
[1,2]. HIF is comprised of two basic-Helix-Loop-Helix/Per-Arnt-
Sim domain (bHLH/PAS) proteins, known as HIF-a and HIF-b
[3], which dimerise in the nucleus to activate transcription [4].
HIF-a subunits are hypoxia responsive, while HIF-b (alternatively
known as ARNT) is constitutively expressed and unresponsive to
hypoxia.
There are three genes encoding HIF-a subunits: Hif1a, which
encodes HIF-1a protein [5]; Epas1, which encodes HIF-2a
protein, also known as HIF-Like Factor (HLF) or Endothelial
Per-ARNT-Sim protein-1 (EPAS1) [6–8]; and Hif3a, which
encodes various splice variants of HIF-3a protein [9,10].
However, only HIF-1 and HIF-2 are active transcription factors,
formed by respective dimerisation between HIF-1a or HIF-2a
with HIF-b. HIF-1a and HIF-2a are not redundant, and have
differing physiological roles, as established by several independent
transgenic and knockout mouse lines [11–15]. In oxygenated cells,
HIF-a subunits are rapidly degraded and inactivated by the
oxygen-dependent PHD and FIH hydroxylases [16–18], but in
hypoxic conditions they are stabilised and transactivate specific
genes such as Vegf [19] and Dec1 [20]. Both forms of HIF bind
directly to a DNA sequence known as the Hypoxia Response
Element (HRE), with a consensus sequence of RCGTG [1,3,21].
Known HREs are most commonly found within 2kb of the target
gene transcription start site (TSS) [22], however there are
examples of more distant functional HREs, such as that of the
Phd3 gene which is found over 10 kb from its TSS [21].
Differences between HIF-1 and HIF-2 target selection are caused
by interaction with other transcription factors or chromatin
context, rather than through DNA target sequence selection
[23,24].
Rgs4 is a member of a large family of genes encoding RGS G-
Protein signalling regulators, which bind to GTP-bound Ga and
increase the rate of GTP hydrolysis, causing reduced signal
transduction from the associated G-protein coupled receptors [25–
27]. Rgs4 is expressed predominantly in neural and vascular cells
[28,29], and the Rgs4 locus has been linked to disease states
relating to both types of cell, notably in schizophrenia [30].
Although the causes of schizophrenia are not yet understood, one
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major theory involves dysregulation of dopamine signalling [31],
so it is interesting that RGS4 protein is capable of inhibiting signal
transduction from the D2 dopamine receptor [32,33]. Notably,
schizophrenia risk is also linked to reduced oxygen availability
during foetal and post-natal development [34–37]. Rgs4 is related
to Rgs5 in sequence, function and regulation, and both gene
products have roles in cardiovascular development and homeo-
stasis [38]. RGS4 and RGS5 proteins have been previously shown
to be protected from degradation by hypoxia and nitric oxide
[38,39], while Rgs4 also appears in a list of hypoxia upregulated
genes in the SK-N-BE(2)C cell line [40]. However, no mechanistic
link between Rgs4 gene regulation and hypoxia has been reported.
Although there are numerous characterised HIF target genes
[1], a majority of these have been discovered in a limited number
of specific cell types, particularly breast and kidney cancer cell
lines. The PC-12 rat pheochromocytoma, SK-N-SH and SK-N-
BE(2)C human neuroblastoma cell lines all stabilise and activate
both HIF-1a and HIF-2a protein endogenously in hypoxia
[41,42], and are derived from tumours of the sympathetic nervous
system. Therefore, to identify novel HIF-regulated target genes we
developed an inducible expression system to selectively express
either HIF-1a or HIF-2a in PC-12 rat pheochromocytoma cells,
and performed siRNA-targeted knockdown of endogenous HIF-
1a or HIF-2a in neuroblastoma cells. We report gene expression
analysis demonstrating that Rgs4 is a cell-type specific hypoxia
inducible target in PC-12 and neuroblastoma cell lines, under the
control of HIF-1 and HIF-2. The use of hypoxia mimetics
targeting the HIF hydroxylases and siRNA knockdown experi-
ments confirm a role for the endogenous HIFs in hypoxic
regulation of Rgs4, but not Rgs5.
Methods
Tissue Culture
PC-12 rat pheochromocytoma cells [43] were grown in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
10% Horse Serum and 5% Fetal Calf Serum (FCS). Neuro-2A
mouse neuroblastoma [44] and SK-N-SH human neuroblastoma
cells [45] were grown in Minimal Essential Medium (MEM)
supplemented with 10% FCS. SK-N-BE(2)C human neuroblasto-
ma cells [46] were grown in RPMI-1640 supplemented with 10%
FCS. Human Umbilical Vein Endothelial Cells (HUVECs) were a
kind gift from Dr Claudine Bonder (Institute of Medical and
Veterinary Science, South Australia) [47]. Cells were maintained
at 37uC and 5% CO2, and passaged with trypsinisation when
near-confluent, and hypoxic conditions (,0.5% O2) were achieved
by sealing the culture vessel inside an airtight container along with
an AnaeroGen sachet (Oxoid). Cells were treated with 1 mM
dimethyloxalylglycine (DMOG), 100 mM 2,29-dipyridyl (DP) or
DMSO as a negative (vehicle) control.
Plasmid Construction
pEF/TetON/IRES/PURO was constructed by transferring the
EcoRI and BamHI (blunted) fragment from pTET-On (Clontech)
into EcoRI and EcoRV digested pEF/IRES/PURO [48]. To
construct pEF/TetON/IRES/NEO, pEF/TetON/IRES/PURO
was digested with NheI and NotI and the 1 kb fragment inserted
into NheI and NotI digested pEF/IRES/NEO. pTR/DC/EYFP
was generated by cloning the SspI and NcoI fragment from pTR5-
DC/GFP [49] into SspI and NcoI digested pIRES-EYFP
(Clontech). To construct pTR/HIF-2a/DC/EYFP, pHIF-2a/
SL301 was digested with HpaI and EcoRV and the 3 kb fragment
ligated into PmeI digested pTR/DC/EYFP. To construct pTR/
HIF-1a/DC/EYFP, pET-32a/HIF-1a was digested with BglII
and BamHI and the 2.5 kb fragment cloned into BglII digested
pTR/DC/EYFP. The resultant construct was termed pTR/HIF-
1a C-terminus/DC/EYFP. To introduce the N-terminus of HIF-
1a, pET-32a/HIF-1a was digested with BglII and the 0.1 kb
fragment transferred into BglII digested pTR/HIF-1a C-termi-
nus/DC/EYFP. To then construct pTR/HIF-1aN803A/DC/
EYFP, pEFBOS/HIF-1aN803A was digested with AflII and HpaI
and the 1.3 kb fragment purified and inserted into pTR/HIF-1a/
DC/EYFP (from which a 1.3 kb fragment was also released).
Tet-ON PC-12 Cell Line Development
The parental monoclonal PC-12/TetON/NEO cell line was
established from PC-12 cells transfected with 10 mg of pEF/
TetON/IRES/NEO and supplementation of the medium with
200 mg/mL of G418. The individual colony displaying the greatest
reverse tetracycline transactivator (rtTA) activity was maintained
for the establishment of subsequent lines. PC-12/TetON/NEO
cells were transfected with 5 mg of pTR/DC/EYFP, pTR/HIF-
2a/DC/EYFP or pTR/HIF-1aN803A/DC/EYFP. After multi-
ple passaging and exposure to 2 mg/mL doxycycline for 16 hours,
FACS was performed and all fluorescing cells were collected. After
cultivation, these cells were once again exposed to 2 mg/mL of
doxycycline for 16 hours, FACS performed and the highest
fluorescing cells selected (approximately 5%). Monoclonal lines
were generated by limiting dilution, and then HRE activity was
analysed using reporter assays and HIF-1a and HIF-2a protein
was detected via immunoblotting. Separation of proteins for
immunoblotting was performed via the electrophoresis of equiv-
alent amounts of whole cell extracts through 7.5% acrylamide tris/
glycine SDS PAGE gels. The membrane was blocked for 1 hour in
10% milk, phosphate-buffered saline, and 0.1% Tween 20 (PBST),
incubated overnight with 1/500 dilution of primary antibody
(polyclonal rabbit anti HIF-1a amino acids 727–826 or polyclonal
rabbit anti HIF-2a amino acids 612–823), diluted in 10% milk,
phosphate-buffered saline, and 0.1% Tween 20. The membrane
was washed three times for 10 minutes in phosphate-buffered
saline and 0.1% Tween 20 prior to incubation in 2.5% milk, PBST
and 1/2000 (DAKO) or 1/20000 (Pierce) dilution of horse radish
peroxidase conjugated goat anti rabbit immunoglobulin for 1
hour. The membrane was washed three times for 10 minutes in
PBST and blotted dry and analysed by chemiluminescence with
autoradiography.
Microarray
Four 175 cm2 flasks of PC-12/TetON/EYFP and PC-12/
TetON/HIF-2a/EYFP cells were exposed to 2 mg/mL doxycy-
cline or left untreated for 16 hours for each treatment. Total RNA
was prepared, then cDNA synthesis and labelling reactions
performed using a mixture of random hexamers, labelled poly
dT oligonucleotides and Cy3 and Cy5 dyes, according to the
established protocols at the Adelaide Microarray Facility, which
have been described previously [50]. Hybridisation of the labelled
RNA to 10 K rat oligonucleotide microarray slides (Clive and
Vera Ramaciotti Centre for Gene Function Analysis, Australia)
was performed according to the manufacturer’s instructions.
Statistical analysis was achieved using the using the Spot v3
plugin (CSIRO, Australia) within the R statistical software package
(http://www.R-project.org), as detailed previously [50].
Gene Expression Analysis
After the indicated treatment, cells were lysed and RNA
extracted with TriReagent (Sigma), as per the manufacturer’s
protocol. RNA integrity was assessed by spectrophotometry
(Eppendorf BioPhotometer) and gel electrophoresis. For northern
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blotting, 20 mg of total RNA was run on a formamide/MOPS/1%
agarose gel, and transferred to Nytran membrane (Schleicher and
Schuell) by passive blotting. 32P-dATP labelled DNA probes were
generated from cDNA clones, originally made from cDNA
fragments amplified by RT-PCR using the following primer
sequences: Rgs4: ATG TGC AAA GGA CTC GCT GGT, TTA
GGC ACA CTG AGG GAC TAG; Vegf: GCC TTG CTG CTC
TAC CTC CAC, CAA ATG CTT TCT CCG CTC TGA; b-
Actin: CTG GCA CCA CAC CTT CTA C, GGG CAC AGT
GTG GGT GAC.
32P-dATP labelled cDNA probes were hybridised to the Nytran
membrane overnight at 42uC in 50% formamide with 5x SSC
buffer, 50 mM NaPO4 (pH 6.5), 5x Denhardt’s solution, 0.1%
SDS and 0.3 mg/mL sheared salmon sperm DNA. The mem-
branes were washed twice with 2x SSPE/0.1% SDS at 42uC and
once with 0.1x SSPE/0.1% SDS at 65uC, then exposed to a
phosphorimaging plate for 48–72 hours before scanning and
analysis with a Typhoon Trio instrument (Amersham Biosciences)
and QuantityOne software (Bio-Rad). Probes were stripped from
membranes by boiling in 10 mM Tris (pH 7.5) and 0.1% SDS for
5 minutes before reprobing.
For quantitative reverse transcription PCR (qRT-PCR), 2 mg of
total RNA was used as a template for cDNA synthesis with both
random hexamer and poly-dT priming. Quantitative PCR was
run in triplicate for each cDNA sample, using Fast SYBR Green
Mastermix (Applied Biosystems) as per the manufacturer’s
protocol, primers as specified in supplementary material, and the
StepOne Plus thermal cycler (Applied Biosystems). Negative
controls without reverse transcriptase were run for each experi-
ment. qPCR efficiency was calculated for each primer set to be
0.9,E,1.1, and amplification specificity was ensured by gel
electrophoresis of PCR products, and melting curve analysis.
Target gene expression was calculated relative to reference gene
(Polr2a) expression for each experiment using the DDCt method
and Q-Gene software [51]. For statistical analysis, each indepen-
dent experiment was normalised to the control to yield fold change
in target gene expression, then mean and standard deviation
across independent experiments calculated.
For statistical analysis of gene expression data using pooled data
from independent biological replicates, the 99% confidence
interval was calculated for each treatment, using the mean fold
change, standard deviation and number of biological replicates.
Statistical significance was assigned to treatment samples for which
Figure 1. Generation and verification of PC-12 TetON HIF-a inducible expression cell lines. (A) PC-12/TetON/EYFP, PC-12/TetON/HIF-2a/
EYFP and PC-12/TetON/HIF-1a/EYFP cells were transfected with a firefly luciferase reporter gene containing 4 copies of the HRE (pHRE4) or a control
construct which lacks the HRE (pGL3). 6 hours post transfection, cells were exposed to 20% O2 or ,1% O2 in the presence or absence of 2 mg/mL
doxycycline (Dox). After 16 hours, cells were assayed for firefly luciferase activity against a cotransfected internal renilla luciferase control. Results
representative of 3 independent experiments performed in triplicate. Error bars represent standard deviation. (B) Cell extracts were prepared from
cells treated as in (A), and 20 mg of total protein from each was analysed by immunoblotting with antibodies to HIF-1a (upper immunoblot) or HIF-2a
(lower immunoblot).
doi:10.1371/journal.pone.0044564.g001
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Figure 2. Rgs4 is responsive to hypoxia and hypoxia-mimetic chemicals. (A) Northern blot of total RNA from parental PC-12 cells with or
without 16 hours of hypoxic treatment, and the TetON-Control, TetON-HIF1a and TetON-HIF-2a PC-12 cell lines with or without 16 hours of
doxycycline treatment (Dox). Blot shown is representative of either three (Rgs4 with doxycycline treatments), two (Rgs4 with hypoxia, Vegf with
doxycycline) or one (Vegf with hypoxia) independent experiments. (B) SK-N-SH cells were treated with normoxia, hypoxia, 0.1% DMSO (vehicle), 1 mM
Hypoxic Induction of Rgs4 Is Mediated by HIF
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the control treatment value (set at 1) lies outside of the 99%
confidence interval.
siRNA Knockdown
siRNA duplexes (Qiagen) targeted specific sequences described
in [52]. Subconfluent cells were transfected twice sequentially with
50 nM siRNA using siLentFect reagent (Bio-Rad), before
replacement of media, and treatment with DP or vehicle as
described above. Whole cell extracts from duplicate samples were
obtained through lysis of cells in 1x Laemmli buffer, separated by
7.5% SDS PAGE, and transferred to nitrocellulose, and analysed
as described above.
Actinomycin D Treatment
Cells were treated with 4 mg/mL actinomycin D [53], or
equivalent DMSO as a negative vehicle control, then incubated in
normoxia or hypoxia, and gene expression was analysed by qRT-
PCR as described previously. Rgs4 mRNA level decay was
calculated in relation to total RNA levels, as well as after
normalisation to reference gene Polr2a. Values from two indepen-
dent experiments without normalisation were entered into Prism
(GraphPad) and graphed as an x,y scatter plot with one phase
decay line fitted, constraining the plateau to 0. Calculated half-life
ranges at 99% confidence were then computed by Prism software.
DMOG or 100 mM DP for 16 hours before target gene analysis by qRT-PCR. Mean fold change with standard deviation for three independent
experiments is shown. (C) PC-12 and (D) SK-N-BE(2)C cell lines were tested in two independent experiments as in 1(B). Representative experiments
(from n=3) are shown. (E) SK-N-BE(2)C and HUVEC cell cultures were treated with 0 (normoxia), 3 and 16 hours of hypoxia before quantification of
Rgs4, Rgs5 and Vegf mRNA levels relative to Polr2a using qRT-PCR, normalised to normoxic levels. Mean fold change with standard deviation for three
independent experiments is shown. Asterisks indicate that the normoxic control lies outside of the 99% confidence interval of relative mean target
gene expression.
doi:10.1371/journal.pone.0044564.g002
Figure 3. Knockdown of HIF-a subunits impairs response of Rgs4. SK-N-BE(2)C cells were transfected twice with 50 nM of negative control
siRNA, or siRNA targeted towards Hif1a or Epas1 mRNA (siHIF1_1541 or siHIF2_1599, respectively), or 50 nM each of both targeted siRNAs together.
Cells were then grown for 8 hours with 0.1% DMSO vehicle (V) or 100 mM DP before collection and gene expression analysis for Rgs4, Vegf, Dec1, Hif1a
and Epas1 expression levels relative to Polr2a by qRT-PCR. Mean fold change with standard deviation between three independent experiments is
shown, each normalised to the DP-treated level of expression of each gene after negative control siRNA transfection, with asterisks indicating that the
DP-treated control lies outside of the 99% confidence interval of relative target gene expression.
doi:10.1371/journal.pone.0044564.g003
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Figure 4. Rgs4 response is not due to mRNA stability or indirect transcriptional activation. (A) SK-N-BE(2)C cells were treated with 4 mg/ml
actinomycin D prior to treatment with 4, 8 or 12 hours of normoxia or hypoxia. Untreated cells were also used to give control normoxic (0 hours) and
hypoxic (8# hours) Rgs4 levels. Rgs4 mRNA levels were quantified using qRT-PCR relative to Polr2a, then normalised to normoxic levels. One
representative of n= 2 is shown. Rgs4 (B) and Polr2a (C) mRNA levels relative to total RNA were also calculated from C(t) values without normalisation
Hypoxic Induction of Rgs4 Is Mediated by HIF
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Luciferase Reporter Assays
TetON PC-12 cells were transiently transfected using Lipofec-
tamine2000 (Invitrogen) with 100 ng of pRLTK (Promega) and
100 ng of pHRE4 (pHRE4GL3, provided by Yoshiaki Fujii-
Kuriyama, Tohoku University, Japan [7]) or pGL3 (Promega) and
were then left untreated or treated with 2 mg/mL doxycycline,
both with or without additional exposure to hypoxia, for 16 hours.
For later experiments, SK-N-BE(2)C cells in 24-well trays were
transfected twice sequentially over two days with 100 ng of pGL3
or 25 ng of pHRE4 firefly luciferase reporter and 25 ng of
phRLCMV renilla luciferase reporter in 0.5 mL serum-free media
per well. Sequences flanking the human Rgs4 gene were cloned by
genomic PCR (primer sequences available in supplementary data)
and subcloned to the MCS of pGL3. For 39UTR analysis, Rgs4
sequence K was subcloned between the luc+ coding sequence and
polyadenylation signal site and transfected as per the pGL3-based
vectors. Cells were then treated with hypoxia or normoxia for 16
hours, and luciferase expression was measured using the Dual
Luciferase System (Promega) and luminometer (Promega) as per
the manufacturer’s protocol.
Results
Generation of TetON Inducible PC-12 Cell Lines and
Analysis of Gene Expression by Microarray
In order to investigate novel, cell-type specific HIF target genes,
HIF-1a and HIF-2a tetracycline inducible (TetON) monoclonal
PC-12 cell lines were established. To characterise HIF induction,
cells were transfected with pHRE4 or pGL3 luciferase reporter
genes and treated with 2 mg/mL doxycycline or vehicle control,
and exposed to normoxia or hypoxia. Cells were assayed for
luciferase activity (Figure 1A) and for HIF-1a or HIF-2a protein
levels by immunoblotting (Figure 1B).
As anticipated, hypoxia induced HIF-1a and HIF-2a protein
expression and HRE-dependent activity in all cell lines. Impor-
tantly, doxycycline treatment induced HRE activity in both HIF-
inducible cell lines, by inducing the expression of HIF-2a protein
in the PC-12/TetON/HIF-2a/EYFP cell line and HIF-1a protein
in the PC-12/TetON/HIF-1a/EYFP cell line.
Due to the low inducibility of the HRE reporter gene by HIF-1a
in the stable cell lines (data not shown), the HIF-1a N803A mutant
which prevents asparaginyl hydroxylation by FIH was used [18],
resulting in similar HRE induction to the HIF-2a line (Figure 1A).
This was not surprising as overexpression of wildtype HIF-1a
protein, but not HIF-2a, has been reported to require hypoxia for
full transcriptional activity [54], and HIF-1a has also been shown
to be a better substrate for FIH than HIF-2a [55].
Interestingly, although the overexpressed HIF proteins are likely
to avoid degradation due to saturation of the PHDs, over
expression and stabilisation of one of the HIFs using doxycycline
does not appear to stabilise the other endogenous HIF.
Rgs4 Gene Expression Profiling
To identify HIF-2a target genes, a cDNA microarray was
performed using RNA extracted from PC-12/TetON/HIF-2a/
EYFP cells treated with 2 mg/mL of doxycycline or vehicle control
for 16 hours. As expected, the transcript most induced by
doxycycline treatment of the PC-12/TetON/HIF-2a/EYFP cell
line was HIF-2a (a 15.5 fold increase), whereas transcript levels of
HIF-1a remained unchanged, validating the array (data not
shown). One of the genes showing the greatest induction with HIF-
2a overexpression compared to the control cell line was Rgs4 (2.1
fold). This was comparable to Vegf, a well-characterised target gene
of both HIF-1 and HIF-2 [8,19,56,57], whose expression was
increased 1.9 fold. Hence Rgs4 expression was further examined
by northern blot for response to 16 hours of doxycycline-induced
overexpression in both of the HIF TetON PC-12 cell lines (using
mRNA from independent samples to those used in the micro-
array), and also for response to 16 hours of hypoxic treatment in
the parental PC-12 cells (Figure 2A). Overexpression of HIF-1a or
HIF-2a increased Vegf mRNA relative to loading controls as
expected, and the effect of HIF-1a was greater than that of HIF-
2a. The basal levels of Rgs4 were altered by the stable transfection
of the doxycycline-regulated vectors compared to unmodified PC-
12 cells, therefore untreated controls were included for all
modified cell-lines. However, some changes in gene expression
due to doxycycline-induced HIF-a overexpression may be masked.
Rgs4 mRNA was consistently elevated in both HIF-2a overex-
pressing and hypoxic parental PC-12 cells compared to the
relevant controls (Figure 2A), but no reproducible regulation of
Rgs4 by overexpressed HIF-1a was detected. This is consistent
with Rgs4 being a HIF-2a target in PC-12 cells.
As Rgs4 displays cell-specific expression, the hypoxic regulation
of Rgs4 in other cell types was investigated, including human
neuroblastoma SK-N-SH and SK-N-BE(2)C cells. Total RNA was
extracted after normoxic or hypoxic treatment of each cell type,
and analysed by northern blot and quantitative RT-PCR for
expression of Rgs4, and the well characterised HIF target gene Vegf
(Figure 2B–D). Vegf and Rgs4 mRNA expression was readily
detectable and hypoxically induced, with a similar level of
response to that observed in parental PC-12 cells (Figure 2B–D).
Mouse neuroblastoma Neuro-2A cells were also tested, with
similar results (data not shown). Furthermore, treatment of PC-12,
SK-N-SH, SK-N-BE(2)C and Neuro-2A cells with hypoxia
mimetics dimethyloxallylglycine (DMOG) or 2,29-dipyridyl (DP)
resulted in increased Rgs4 levels relative to controls. DMOG and
DP are both known to mimic the transcriptional hypoxic response
by antagonising the HIF hydroxylases PHD1-3 and FIH, resulting
in stable and active HIF heterodimers [16,17]. However, Rgs4
mRNA was not detectable in 293T or P19 extracts (data not
shown). Together these data demonstrate the cell-specific induc-
tion of Rgs4 by hypoxia in pheochromocytoma and neuroblastoma
cells, and are consistent with a role of the HIF pathway in this
response.
Rgs5 encodes another member of the RGS domain protein
family with high homology to Rgs4, and the two genes are
separated by only 65 kb on Chromosome 1 according to the
UCSC human genome browser [58]. Previous studies have
reported that Rgs5, but not Rgs4, is responsive to hypoxia in
Human Umbilical Vein Endothelial Cells (HUVECs) [59].
Therefore, we compared hypoxic induction of Rgs4 and Rgs5 in
to reference gene relative to normoxia. The mean detection with standard error (n= 2) is plotted to give a one-phase decay using GraphPad Prism 5.
Estimated mRNA half-lives are described in the text. (D) SK-N-BE(2)C cells were transfected twice with 100 ng of pCI_FL (control) or pCI_FL
incorporating the 39UTR of human Rgs4 (hRgs4_39UTR). Mean relative luciferase units with standard deviation from 3 replicate wells of one
experiment are shown as a representative of n= 3. (E) SK-N-BE(2)C cells were treated with 100 mM DP for 1, 2, 4 8 or 16 hours in comparison to an
untreated (0 hours) control. Message levels were quantified by qRT-PCR for indicated transcripts relative to reference gene Polr2a, then normalised to
normoxic levels. Data is presented as the mean and standard deviation from three independent experiments. Asterisks indicate that control level lies
outside of the 99% confidence interval of the DP-treated target gene expression.
doi:10.1371/journal.pone.0044564.g004
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HUVEC cells to the SK-N-BE(2)C neuroblastoma cells which
display strong Rgs4 induction. 3 or 16 hour hypoxic treatment of
SK-N-BE(2)C resulted in significant and reproducible increases in
Rgs4 expression (2.8860.34 and 5.4660.70 fold, respectively).
However, no significant changes in Rgs5 expression were observed
after either 3 hour (0.9860.24) or 16 hour (1.6460.68) hypoxic
Figure 5. Functional hypoxia responsive elements cannot be detected within 33 kb of the human Rgs4 gene. (A) Diagram of the human
Rgs4 locus, with HRE-like sequences depicted by crosses, and the regions (A-N) that were cloned by genomic PCR and inserted into pGL3 upstream of
the luc+ coding sequence. Primer sequences for PCR are listed in Table S1. hRgs4 splice variants and regions of high conservation within mammals as
shown as depicted by UCSC Genome Browser. (B) SK-N-BE(2)C cells were transfected twice with 100 ng of pGL3promoter (-) or pGL3-based reporter
plasmids incorporating the genomic sequences depicted in (A), while 25 ng pHRE4 was transfected separately as a positive control for hypoxia
treatment. Cells were treated with hypoxia for 16 hours, before relative luciferase expression analysis. Mean relative luciferase units of triplicate wells
with standard deviation are depicted, as a representative of three independent experiments.
doi:10.1371/journal.pone.0044564.g005
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treatment of cells (Figure 2E). Interestingly, neither Rgs4 nor Rgs5
were induced by hypoxic treatment of HUVEC cells, but instead a
small yet significant decrease in the expression of both Rgs4
(0.5160.24) and Rgs5 (0.6960.13) was detected after 16 hours of
treatment. In contrast, there was a strong induction of the positive
control Vegf. These results demonstrate that Rgs4 and Rgs5 are not
hypoxically inducible in HUVECs under the conditions tested.
Role of Endogenous HIF-1a and HIF-2a in Rgs4 Hypoxic
Induction
In order to directly implicate the endogenous HIF transcription
factors in regulation of Rgs4, siRNA duplexes targeted at either
Hif1a or Epas1 mRNA at previously defined sites [52] were used.
SK-N-BE(2)C cells were transfected with either an siRNA towards
either Hif1a or Epas1, both simultaneously, or a control siRNA,
before activation of the HIF pathway with the hypoxia mimetic
DP for 8 hours. Gene expression was analysed in response to the
HIF knockdowns by qRT-PCR for Rgs4, characterised HIF targets
Vegf [19] and Dec1 [20], and the HIF-a encoding genes Hif1a and
Epas1. The effect of siRNA knockdown is observed on targeted
Hif1a and Epas1 mRNAs, and confirms the specificity of the HIF-
specific siRNAs. Interestingly, cells downregulated Hif1a while
upregulating Epas1 in response to DP treatment alone in control
siRNA-transfected cells (Figure 3 and Figure S1). Significant
negative effects on Vegf and Dec1 response to DP were observed,
although both of these genes were only sensitive to HIF-1a
knockdown (Figure 3). However, Rgs4 message levels were
sensitive to knockdown of either HIF-a subunit, while knockdown
of both Hif1a and Epas1 produced a more dramatic inhibition of
the response to DP similar to that observed with Vegf and Dec1.
Similar results were achieved using alternative siRNA constructs
designed to target HIF-1a and HIF-2a, although knockdown of
Hif1a and Epas1 was less efficient (Figure S1). Together these data
are consistent with a contribution of both HIF-1a and HIF-2a to
the induction of Rgs4.
Rgs4 Employs a Direct Transcriptional Response to
Hypoxia
In order to determine whether Rgs4 mRNA regulation by
hypoxia is transcription-dependent, SK-N-BE(2)C cells were
plated and treated with actinomycin D to block transcription,
then subjected to a time-course of hypoxic or normoxic treatment
before Rgs4 transcript quantification by qRT-PCR. Rgs4 mRNA
degradation was not significantly different between normoxic and
hypoxic samples when quantified relative to Polr2a (Figure 4A).
Rgs4 and Polr2a mRNA one-phase decay curves relative to total
RNA were plotted, and Rgs4 mRNA half-life was calculated to be
between 3.5–4.0 hours in normoxia, and 4.0–4.6 hours in hypoxia
within a 99% confidence interval. (Figure 4B,C). This small
difference is similar to that observed with Polr2a, and cannot
account for the larger reproducible hypoxic induction of Rgs4
observed in Figure 2. Similarly, despite the presence of several
conserved 39UTR elements, the human Rgs4 39UTR did not
confer hypoxic response to a luciferase reporter gene in SK-N-
BE(2)C cells (Figure 4D), further supporting a transcriptional
induction of Rgs4 by HIF in hypoxia.
To investigate whether the kinetics of Rgs4 induction are
consistent with other direct HIF targets, a hypoxia time-course was
performed from 0 to 16 hours on the SK-N-BE(2)C cell line, and
Rgs4, Vegf, Dec1, Hif1a and Epas1 message levels were quantified
using qRT-PCR. In addition, we tested for levels of Mlh1
transcript, which is negatively regulated by the HIF-inducible
gene product of Dec1 [60], and therefore responds indirectly to the
HIF pathway. The results demonstrate that Rgs4 is significantly
upregulated after 1 hour of hypoxic treatment, similar to the other
direct HIF target genes Vegf and Dec1 (Figure 4E), and is therefore
likely to be a direct target of the HIF transcription factor. In
contrast, the secondary HIF responder Mlh1 displays delayed
regulation, and is not significantly affected by hypoxia until 4
hours of treatment. Curiously, both Hif1a and Epas1 mRNA levels
were again regulated by DP treatment, in a similar timeframe to
the Mlh1 response, indicating that the HIF-encoding genes may be
under indirect self-regulation in this cell-line.
Rgs4-Proximal Genomic Sequences are Unresponsive to
Hypoxia in Reporter Assays
Given the evidence for Rgs4 being a direct transcriptional target
of the HIFs, the Rgs4 promoter was analysed for functional HREs
that mediate the HIF-dependent hypoxic induction. We used the
UCSC Genome Browser [58] to analyse the 32.8 kb sequence of
the human genome containing the Rgs4 promoter, coding
sequence, introns and flanking regions. A search was conducted
using the MBCS program [61] for the minimal HIF binding
consensus sequence RCGTG [1], in both forward and reverse
orientations, resulting in 27 hits, 4 of which result from 2
palindromic CACGTG sequences (Figure 5A). Conservation was
assessed by comparison to mouse and rat genomic sequences using
UCSC Genome Browser, at both primary sequence level and
using the comparative genomics track of the Genome Browser. No
putative HREs were identified which exhibited strong conserva-
tion across species, but we reasoned that enhancer sequences may
have moved during evolution, as has been commonly reported for
other enhancers [62,63]. Alternatively, the Rgs4 HRE may not
conform to the consensus sequence. Therefore, to test the Rgs4
locus for hypoxia responsive enhancers with an unbiased
approach, the genomic regions analysed were divided into
overlapping fragments and each amplified by genomic PCR
(Figure 5A, primer sequences listed in Table S1), before
subcloning into the pGL3 reporter plasmid. Genomic sequences
including the Rgs4 transcription start site replaced the existing
promoter of pGL3, while all other sequences retained this minimal
SV40 promoter to allow expression of Firefly Luciferase. One
short region between sequences C and D could not be cloned
either in isolation or in combination with adjacent regions C and
D, and therefore could not be tested. However HRE-like
sequences were not detected by bioinformatic analysis in this
short region.
The 14 constructs corresponding to 32 kb were transfected into
SK-N-BE(2)C cells together with a constitutive Renilla Luciferase
expressing construct, and treated for 16 hours with hypoxia or
normoxia before analysis by the Dual Luciferase System
(Promega). No significant change in relative luciferase expression
upon hypoxic treatment could be detected in any sequences tested
(Figure 5B–E), similar to the empty pGL3-promoter control. In
contrast, the positive controls demonstrated robust HRE-depen-
dent activation. The hypoxic response of Rgs4 mRNA is also
observed in rat PC-12 cells, so the 5 kb promoter of the rat Rgs4
gene was tested for hypoxic response in PC-12 cells, and similar
results were obtained with no detectable hypoxic induction (data
not shown). Thus, while Rgs4 mRNA is clearly induced by
hypoxia, this induction does not appear to be mediated by the
32 kb sequence surrounding the Rgs4 gene, and the putative HREs
contained within this sequence are not functional in this context.
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Discussion
The experiments presented here show that Rgs4 is positively
upregulated by hypoxia and hypoxia-mimetic chemicals DMOG
and DP in the PC-12, Neuro-2A, SK-N-SH and SK-N-BE(2)C
cell lines, and this regulation is sensitive to knockdown of HIF-1a
and HIF-2a. In the human neuroblastoma cell lines, Rgs4 is
responsive to hypoxia in a similar timeframe to other direct targets
of HIF transactivation, and a dissimilar timeframe to indirect HIF-
responsive genes. Furthermore, Rgs4 mRNA is not regulated by
hypoxia post-translationally, and the highly conserved regions of
the Rgs4 39UTR do not confer hypoxia sensitivity to a reporter
gene. These results are all consistent with HIF acting directly as a
transactivator on Rgs4 transcription.
Notably, these responses of Rgs4 have only been seen in
sympathetic cancer cell types such as neuroblastoma and
pheochromocytoma, while previously characterised HIF target
genes are regulated by hypoxia in a wider array of cell types, such
as HUVECs. Contrary to other previous findings [59], we could
not detect a hypoxic response for either Rgs4 or Rgs5 mRNA levels
in HUVEC cells. This may be explained by our use of the more
sensitive qRT-PCR expression quantification technique [59]. Our
experiments demonstrate that Rgs4 expression is regulated by
hypoxia in only a subset of cell types that express Rgs4, and that
hypoxic response is not common for all RGS encoding genes, but
is specific for Rgs4.
Rgs4 is expressed strongly in neural and vascular cell types, yet
there are few well-elucidated physiological roles for its gene
product. RGS4 protein can regulate signalling from the m-opioid
(morphine) and/or d-opioid receptors depending on context [64–
66], and also the D2R dopamine receptor [32,33]. Rgs4
dysfunction is thought to be related to disease states such as
schizophrenia [30] and heart hypertrophy [29,67,68]. Increased
Rgs4 expression has also been noted during both epithelial and
endothelial tubulogenesis [69]. Our experiments suggest that any
role for hypoxia in regulating Rgs4 function would most likely
affect the neural roles of Rgs4, rather than its function in the
vascular system, although a wider range of cell types needs to be
tested. Importantly, hypoxia and ischaemia have also been
associated with schizophrenia [34–37], and as such HIF regulation
of Rgs4 transcription in specific neural cell types may provide a
molecular mechanism linking disrupted oxygen supply to schizo-
phrenia.
We demonstrate that hypoxic regulation of Rgs4 requires
transcription and occurs in the same timeframe as other direct
HIF transactivation targets. This implies a direct function for the
HIF transcription factor in activation of Rgs4 gene transcription.
Other known hypoxia and HIF responsive genes are regulated by
direct interaction between HIF and DNA at the regulated gene,
and genomic HIF binding sites are often found within 2k b of a
responsive promoter [22], which can commonly be characterised
by reporter assay. However, no region of the human Rgs4-
proximal locus tested confers hypoxic response as an enhancer
when cloned into a luciferase reporter assay, hence no functional
HRE could be detected in the 32 kb genomic sequence
surrounding the transcription start site of the Rgs4 gene. As there
is some suggestion that Rgs4 is also regulated by other bHLH/PAS
family transcription factors such as NPAS4 [70], we searched
published ChIP-Seq (Chromatin IP with deep Sequencing) data
for NPAS4, CBP and PolII genomic binding sites at the mouse
Rgs4 locus [71]. Importantly, CBP is recruited by HIF-a subunits
via their C-terminal transactivation domains in hypoxia, so DNA
binding sites of NPAS4 and CBP may provide further insight into
likely locations of hypoxia-responsive enhancers. Although this
study used mouse cortical neurons undergoing depolarisation
stimulation as a model, it is clear that mouse Rgs4 is under the
control of several distant enhancers, unlike other known target
genes of NPAS4 such as Drebrin. Specifically, NPAS4 and p300 are
associated with a number of sites distal to the Rgs4 gene, with some
sites of high occupancy for CBP and/or NPAS4 between 20 and
50 kb upstream of the Rgs4 transcription start site, well beyond the
region analysed in reporter assays. Therefore, it is likely that Rgs4
may similarly be under the regulation of HIF acting from a distant
cis binding site, probably interacting with the Rgs4 promoter
through DNA-looping. These sites may be shared with NPAS4, as
DNA binding specificity is similar between HIF and NPAS4 [14],
or they may be distinct. This model may provide an explanation
for the differential regulation of Rgs4 by hypoxia between neural
and vascular cell types, as basal activation of the Rgs4 promoter
may be under different regulation to activation of distant
enhancers. As such, a complex enhancer-promoter interaction
may require additional cell type specific cofactors or chromatin
organisation to enable transactivation of Rgs4 transcription by
HIF.
Whilst we demonstrate here that Rgs4 is induced by hypoxia via
a HIF-mediated mechanism in specific cell types, it is likely that a
detailed ChIP-Seq approach for HIF-1 and HIF-2 using
neuroblastoma cells will be required to definitively identify the
DNA binding site for HIF. Such an approach can also identify
other required factors or chromatin context, and thus may provide
a mechanism for the cell-type specific regulation of Rgs4. It is also
of interest to note that RGS4 protein stability has also been
reported to be regulated by an alternative hypoxia-responsive
pathway, the N-end rule pathway [38], supporting a complex
regulation of Rgs4 at multiple levels in response to hypoxia. Given
that expression of Rgs4 has been linked to diseases such as
schizophrenia, where hypoxia is also thought to be a contributing
factor, the hypoxic regulation of Rgs4 in neural-like cells
demonstrated here is of considerable relevance and supports
further characterisation of the contributions of both Rgs4 and HIF
to this and other diseases.
Supporting Information
Figure S1 Knockdown of HIF-a subunits impairs re-
sponse of Rgs4 to hypoxia. SK-N-BE(2)C cells were
transfected twice with 50 nM siRNA (secondary sequences),
before 8 hours 0.1% DMSO vehicle (V) or 100 mM DP treatment.
Cells were then analysed for Rgs4, Vegf, Dec1, Hif1a and Epas1
expression levels relative to Polr2a by qRT-PCR. Level of each
target mRNA is shown, normalised to the DP-treated level of
expression of each gene after negative control siRNA transfection.
A representative of three independent experiments is shown.
(EPS)
Table S1 Sequences of primers used to clone regions of the
human Rgs4 gene and locus. PCR from genomic template was
performed using listed primers, incorporating restriction enzyme
sites. Products were then cloned to the enhancer, promoter or 39
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